B3 SA - Brasil, Bolsa, Balcao (B3SA3) Q2 2026 Earnings Report

The earnings call presented a broadly positive operational and financial picture: strong top-line growth (revenues +12%), healthy recurring revenue expansion (+17%), solid EBITDA margin (70%) and significant net income improvement (+28% reported). Management highlighted product innovation and renewed capital markets activity. Key risks include a recent operational outage (market opening delay), an increase in statutory tax rates (temporarily offset by nonrecurring interest on capital), ongoing antitrust review and some volume softness in derivatives and seasonal equity deceleration. Overall, the positive financial results, recurring revenue momentum and product pipeline outweigh the described challenges, though operational and regulatory uncertainties warrant monitoring.

Management's guidance was to accelerate execution of the existing strategy while prioritizing operational resilience after the July 31 technical failure, with mitigation measures already underway and no expectation of a material increase in CapEx or SG&A this year (the company already invests about 10% of net revenues in OpEx+CapEx/product development). They plan to continue deploying nonrecurring interest‑on‑capital (IoC) balances (BRL 5.5bn initial pool, BRL 1.5bn used in 2025, BRL 750m recognized this quarter and similar amounts planned to year‑end, with the remainder likely used next year), noting the IoC tax benefit more than offset the rise in the nominal statutory tax rate from 34% to 37% as of April (a further increase has been flagged toward 2028); recurring revenues (≈50% of total) grew 17% in Q2 and management expects similar underlying growth, while procyclical revenues rose 8% (Q2 total revenues BRL 3.1bn, +12% YoY), recurring EBITDA was BRL 1.9bn (+13%) with a 70% margin, reported net income BRL 1.7bn (+28%) and recurring EPS BRL 0.28 (+12%); antitrust discussions may take up to a year but are not expected to materially affect revenues, and seasonality/election dynamics remain: July typically runs 10–15% below prior‑6‑month averages (≈20% in election years) with recovery thereafter.